Durvalumab after Sequential Chemoradiotherapy in Stage III, Unresectable NSCLC: the Phase 2 PACIFIC-6 Trial.
Journal of thoracic oncology(2022)
关键词
Durvalumab,Immunotherapy,Sequential che-moradiotherapy,Non-small-cell lung cancer,Locally advanced
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要